Xavier Orcutt, Vivek Nimgaonkar, Lova Sun, Charu Aggarwal, Aaron B. Cohen, Ronac Mamtani, Qi Long, Ravi Bharat Parikh. "Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumab.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e20523